Patent 7384648 was granted and assigned to Allergan, Inc. on June, 2008 by the United States Patent and Trademark Office.
An implant device is provided which incorporates a retinoid for improving the biocompatibility of the device in tissue. The device may be bioerodible for the purpose of systemically or locally releasing a therapeutic agent in tissue or it may be a permanent implant which includes a surface treated with a retinoid for increasing the biocompatibility thereof.